Zhongchao Inc

Zhongchao Inc(ZCMD)股票分析

$0.965

+0.007 (+0.73%)收盤時

Loading chart…
最高
1.035
開盤
0.946
成交量加權均價
0.98
成交量
91.16K
市值
3.23M
最低
0.946
成交金額
89.54K
企業價值/稅息折舊攤銷前利潤(TTM)
0.00

Zhongchao Inc is a holding company primarily engaged in the provision of healthcare information, education, and training services to healthcare professionals and the public. The Company is primarily engaged in the provision of medical training and education services and assistance in patient-aid projects through MDMOOC online platform and offline formats. The MDMOOC online platform includes MDMOOC mobile application (App), MOOC Medical WeChat subscription account, and MDMOOC website. Under the MDMOOC brand, the Company provides various online and onsite health information services, healthcare education programs, and healthcare training products, consisting primarily of clinical practice training, open classes of medical topics, interactive case studies, academic conference and workshops, continuing education courses, and articles and short videos with educational healthcare content. The Company primarily operates its businesses in the domestic market.

AI 分析 of Zhongchao Inc (ZCMD)

持有

Zhongchao Inc. (ZCMD) currently trades at $0.97, which is significantly down 99.87% year-to-date and 99.90% over the past year, indicating severe long-term underperformance. The RSI is at 30.86, suggesting it is oversold, but the forward P/E is 0, indicating no expected earnings growth. The company's gross margin is relatively strong at 55.5%, but it reported a net income loss of $733,276 in the last quarter. The main risk is the company's drastic decline in stock price, which has fallen 39.29% over the last 20 days, reflecting ongoing investor concerns about its viability. Given these factors, it is prudent to hold rather than buy at this time.

估值指標

Zhongchao Inc(ZCMD)目前預期本益比為 0.00,5 年平均預期本益比為 0.00。

預期本益比

嚴重低估
5 年均值 P/E
0.00
目前P/E
0.00
高估
0.00
低估
0.00

預期 EV/EBITDA

嚴重低估
5 年均值 EV/EBITDA
0.00
目前EV/EBITDA
0.00
高估
0.00
低估
0.00

預期股價營收比

嚴重低估
5 年均值 P/S
0.00
目前P/S
0.00
高估
0.00
低估
0.00

Alphio AI 對 ZCMD 的價格情境

情境價格取自當年最後一個月度預測區間。機率為固定的模型權重(25 / 50 / 25),不構成保證。

樂

樂觀

樂觀 · 25%ZCMD

$1.32

情境價格

基

基準

基準 · 50%ZCMD

$1.17

情境價格

悲

悲觀

悲觀 · 25%ZCMD

$1.00

情境價格

事件時間軸

2026-09-30 (ET)

08:30:00

Zhongchao Announces 1-for-2 Share Consolidation

2026-07-23 (ET)

09:30:00

Zhongchao Enters Agreement to Issue 4.55 Million Shares at $1.10

2026-06-25 (ET)

08:31:00

Zhongchao to Effectuate 1-for-3 Share Consolidation

2026-05-07 (ET)

14:50:00

Zhongchao Plans Best-Efforts Offering of 5.56M Units

2026-02-26 (ET)

08:50:00

Zhongchao to Effectuate 1-for-8 Share Consolidation

資訊

ZCMD 常見問題 —— 由 Alphio AI 解答

Zhongchao Inc is a holding company primarily engaged in the provision of healthcare information, education, and training services to healthcare professionals and the public. The Company is primarily engaged in the provision of medical training and education services and assistance in patient-aid projects through MDMOOC online platform and offline formats. The MDMOOC online platform includes MDMOOC mobile application (App), MOOC Medical WeChat subscription account, and MDMOOC website. Under the MDMOOC brand, the Company provides various online and onsite health information services, healthcare education programs, and healthcare training products, consisting primarily of clinical practice training, open classes of medical topics, interactive case studies, academic conference and workshops, continuing education courses, and articles and short videos with educational healthcare content. The Company primarily operates its businesses in the domestic market. It operates in the Academic & Educational Services sector.

Zhongchao Inc. (ZCMD) currently trades at $0.97, which is significantly down 99.87% year-to-date and 99.90% over the past year, indicating severe long-term underperformance. The RSI is at 30.86, suggesting it is oversold, but the forward P/E is 0, indicating no expected earnings growth. The company's gross margin is relatively strong at 55.5%, but it reported a net income loss of $733,276 in the last quarter. The main risk is the company's drastic decline in stock price, which has fallen 39.29% over the last 20 days, reflecting ongoing investor concerns about its viability. Given these factors, it is prudent to hold rather than buy at this time.

暫無貼文

註冊或登入後參與討論

相關文章

本頁僅供研究參考,不構成投資建議。模型可能出錯。過往表現不代表未來結果。

開始交易